title: Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential.
abstract: Insertional mutagenesis by retroviral vectors has emerged as a serious impediment to the widespread application of hematopoietic stem cell gene transfer for the treatment of hematologic diseases. Here we report the development of a 77-base pair element, FII/BEAD-A (FB), which contains the minimal enhancer-blocking components of the chicken beta-globin 5'HS4 insulator and a homologous region from the human T-cell receptor alpha/delta BEAD-1 insulator. With a new flow cytometry-based assay, we show that the FB element is as effective in enhancer-blocking activity as the prototypical 1.2-kilobase 5'HS4 insulator fragment. When incorporated into the residual U3 region of the 3' long terminal repeat (LTR) of a self-inactivating (SIN) gammaretroviral vector, the FB element was stably transferred to the 5' LTR during reverse transcription, flanking the integrated transgene expression cassette. Notably, using a recently established in vitro insertional mutagenesis assay involving primary murine hematopoietic cells, we found that SIN gammaretroviral vectors, as well as SIN lentiviral vectors, containing the FB element exhibited greatly reduced transforming potential-to background levels under the experimental conditions used-compared with their unshielded counterparts. These results suggest that the FB element-mediated enhancer-blocking modification is a promising approach to dramatically improve the safety of retroviral vectors for therapeutic gene transfer.
authors.affiliation: Department of Anatomy and Regenerative Biology, The George Washington University Medical Center, Washington, DC 20037, USA.
authors.forename: Ali
authors.initials: A
authors.lastname: Ramezani
authors.forename: Teresa S
authors.initials: TS
authors.lastname: Hawley
authors.forename: Robert G
authors.initials: RG
authors.lastname: Hawley
mesh_terms: D000818:Animals; D002645:Chickens; D004742:Enhancer Elements, Genetic; D005347:Fibroblasts / Q000378:metabolism; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D016086:Lentivirus / Q000235:genetics; D051379:Mice; D016296:Mutagenesis; D041681:NIH 3T3 Cells; D011401:Promoter Regions, Genetic; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000235:genetics / Q000378:metabolism*; D012190:Retroviridae / Q000235:genetics; D055544:beta-Globins / Q000378:metabolism*
chemical_list: D016693:Receptors, Antigen, T-Cell, alpha-beta; D055544:beta-Globins
references.citation: Mol Ther. 2000 Nov;2(5):458-69
references.pmid: 11082319
references.citation: Nat Med. 2006 Apr;12(4):401-9
references.pmid: 16582916
references.citation: Science. 2005 May 20;308(5725):1171-4
references.pmid: 15905401
references.citation: Mol Ther. 2002 May;5(5 Pt 1):589-98
references.pmid: 11991750
references.citation: Gene. 1991 Dec 15;108(2):193-9
references.pmid: 1660837
references.citation: J Thromb Haemost. 2004 Jan;2(1):111-8
references.pmid: 14717974
references.citation: Blood. 2006 Oct 15;108(8):2545-53
references.pmid: 16825499
references.citation: Biotechniques. 2001 May;30(5):1028-34
references.pmid: 11355338
references.citation: Blood. 2005 Dec 1;106(12):3932-9
references.pmid: 16109773
references.citation: Blood. 2005 Oct 1;106(7):2530-3
references.pmid: 15933056
references.citation: Leukemia. 2008 Aug;22(8):1519-28
references.pmid: 18496560
references.citation: Gene Ther. 1994 Mar;1(2):136-8
references.pmid: 7584069
references.citation: PLoS Biol. 2004 Dec;2(12):e423
references.pmid: 15550989
references.citation: Curr Gene Ther. 2001 May;1(1):1-17
references.pmid: 12109133
references.citation: Gene Ther. 2004 Nov;11(21):1568-78
references.pmid: 15372067
references.citation: Cell. 1988 Sep 9;54(6):831-40
references.pmid: 2842066
references.citation: Science. 2003 Oct 17;302(5644):415-9
references.pmid: 14564000
references.citation: Proc Natl Acad Sci U S A. 1997 May 13;94(10):5219-24
references.pmid: 9144218
references.citation: Blood. 2005 Jun 1;105(11):4235-46
references.pmid: 15713797
references.citation: Blood. 2003 Jun 15;101(12):4717-24
references.pmid: 12586614
references.citation: Proc Natl Acad Sci U S A. 1986 May;83(10):3194-8
references.pmid: 3458176
references.citation: Science. 2001 Jan 19;291(5503):447-50
references.pmid: 11228144
references.citation: Mol Ther. 2006 Jun;13(6):1031-49
references.pmid: 16624621
references.citation: J Virol. 1999 Apr;73(4):2886-92
references.pmid: 10074136
references.citation: J Virol. 1982 Feb;41(2):542-56
references.pmid: 6281466
references.citation: Cell. 1993 Aug 13;74(3):505-14
references.pmid: 8348617
references.citation: Mol Ther. 2005 Dec;12(6):1034-42
references.pmid: 16226058
references.citation: Hum Gene Ther. 2005 Apr;16(4):457-72
references.pmid: 15871677
references.citation: Trends Genet. 2001 Sep;17(9):520-7
references.pmid: 11525835
references.citation: Mol Ther. 2008 Mar;16(3):525-33
references.pmid: 18195719
references.citation: J Virol. 2002 Jul;76(14):7209-19
references.pmid: 12072520
references.citation: Mol Ther. 2006 Aug;14(2):245-54
references.pmid: 16731046
references.citation: Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14354-9
references.pmid: 10588709
references.citation: Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10297-302
references.pmid: 8816794
references.citation: Mol Ther. 2005 Oct;12(4):763-71
references.pmid: 16084128
references.citation: J Clin Invest. 2008 Apr;118(4):1502-10
references.pmid: 18357342
references.citation: Nat Biotechnol. 2006 Jun;24(6):687-96
references.pmid: 16732270
references.citation: Blood. 2004 Jun 1;103(11):4062-9
references.pmid: 14976042
references.citation: Mol Ther. 2007 Apr;15(4):801-9
references.pmid: 17299406
references.citation: Hum Gene Ther. 2006 Mar;17(3):253-63
references.pmid: 16544975
references.citation: Proc Natl Acad Sci U S A. 1997 Jan 21;94(2):575-80
references.pmid: 9012826
references.citation: Proc Natl Acad Sci U S A. 1987 Apr;84(8):2406-10
references.pmid: 3031683
references.citation: Science. 2006 Oct 6;314(5796):126-9
references.pmid: 16946036
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99(10):6883-8
references.pmid: 12011446
references.citation: Curr Opin Cell Biol. 2005 Jun;17(3):251-6
references.pmid: 15901493
references.citation: Gene Ther. 2006 Apr;13(7):641-5
references.pmid: 16355114
references.citation: Science. 2003 Jun 13;300(5626):1749-51
references.pmid: 12805549
references.citation: Mol Ther. 2008 Apr;16(4):718-25
references.pmid: 18334985
references.citation: Curr Protoc Mol Biol. 2002 Nov;Chapter 16:Unit 16.22
references.pmid: 18265303
references.citation: Blood. 2006 May 15;107(10):3865-7
references.pmid: 16439674
references.citation: Cell. 1999 Aug 6;98(3):387-96
references.pmid: 10458613
references.citation: J Virol. 1987 Mar;61(3):925-7
references.pmid: 3806800
references.citation: Methods Mol Biol. 2008;434:183-203
references.pmid: 18470646
references.citation: Gene Ther. 2006 Nov;13(21):1524-33
references.pmid: 16763662